GlassScriptPhysician profile
Charles Grogan
NPI 1447783857
$1,237.73
in general payments reported to CMS, 2019-2025
7 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.59 · 2020: $47.54 · 2021: $438 · 2022: $182 · 2023: $125 · 2024: $208 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489 · Education: $60.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.82 |
| Education | $60.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $453.44 | 2020-2025 | Fasenra |
| Csl Behring | $307.21 | 2019-2025 | Andembry |
| Regeneron Healthcare Solutions, INC. | $168.46 | 2021 | |
| Glaxosmithkline, LLC. | $135.87 | 2020-2022 | |
| Biocryst US Sales Co., LLC | $125.00 | 2023 | Orladeyo |
| Aimmune Therapeutics, INC. | $24.30 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Grogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.